The administration of antisense oligonucleotide golodirsen reduces pathological regeneration in patients with Duchenne muscular dystrophy
出版年份 2021 全文链接
标题
The administration of antisense oligonucleotide golodirsen reduces pathological regeneration in patients with Duchenne muscular dystrophy
作者
关键词
-
出版物
Acta Neuropathologica Communications
Volume 9, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-01-07
DOI
10.1186/s40478-020-01106-1
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Increased dystrophin production with golodirsen in patients with Duchenne muscular dystrophy
- (2020) Diane E. Frank et al. NEUROLOGY
- Safety, Tolerability, and Efficacy of Viltolarsen in Boys With Duchenne Muscular Dystrophy Amenable to Exon 53 Skipping
- (2020) Paula R. Clemens et al. JAMA Neurology
- A high–throughput digital script for multiplexed immunofluorescent analysis and quantification of sarcolemmal and sarcomeric proteins in muscular dystrophies
- (2020) Dominic Scaglioni et al. Acta Neuropathologica Communications
- Long-term natural history data in Duchenne muscular dystrophy ambulant patients with mutations amenable to skip exons 44, 45, 51 and 53
- (2019) Claudia Brogna et al. PLoS One
- Uniform sarcolemmal dystrophin expression is required to prevent extracellular microRNA release and improve dystrophic pathology
- (2019) Tirsa L.E. Westering et al. Journal of Cachexia Sarcopenia and Muscle
- Systemic AAV micro-dystrophin gene therapy for Duchenne muscular dystrophy
- (2018) Dongsheng Duan MOLECULAR THERAPY
- Eteplirsen treatment for Duchenne muscular dystrophy
- (2018) Jay S. Charleston et al. NEUROLOGY
- Exon skipping for Duchenne muscular dystrophy: a systematic review and meta-analysis
- (2018) Yuko Shimizu-Motohashi et al. Orphanet Journal of Rare Diseases
- CD133+ cells derived from skeletal muscles of Duchenne muscular dystrophy patients have a compromised myogenic and muscle regenerative capability
- (2018) Jinhong Meng et al. Stem Cell Research
- DMD CLINICAL THERAPIES II
- (2018) J. Tinsley et al. NEUROMUSCULAR DISORDERS
- NS-065/NCNP-01: an Antisense Oligonucleotide for Potential Treatment of Exon 53 Skipping in Duchenne Muscular Dystrophy
- (2018) Naoki Watanabe et al. Molecular Therapy-Nucleic Acids
- Embryonic myosin is a regeneration marker to monitor utrophin-based therapies for DMD
- (2018) Simon Guiraud et al. HUMAN MOLECULAR GENETICS
- Antisense Oligonucleotide-Based Therapy for Neuromuscular Disease
- (2017) Valentina Sardone et al. MOLECULES
- Development of Exon Skipping Therapies for Duchenne Muscular Dystrophy: A Critical Review and a Perspective on the Outstanding Issues
- (2017) Annemieke Aartsma-Rus et al. Nucleic Acid Therapeutics
- Link between MHC Fiber Type and Restoration of Dystrophin Expression and Key Components of the DAPC by Tricyclo-DNA-Mediated Exon Skipping
- (2017) Saleh Omairi et al. Molecular Therapy-Nucleic Acids
- Antisense molecules: A new class of drugs
- (2016) Daniel P. Potaczek et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- DMDgenotypes and loss of ambulation in the CINRG Duchenne Natural History Study
- (2016) Luca Bello et al. NEUROLOGY
- Correlation of Utrophin Levels with the Dystrophin Protein Complex and Muscle Fibre Regeneration in Duchenne and Becker Muscular Dystrophy Muscle Biopsies
- (2016) Narinder Janghra et al. PLoS One
- Autologous skeletal muscle derived cells expressing a novel functional dystrophin provide a potential therapy for Duchenne Muscular Dystrophy
- (2016) Jinhong Meng et al. Scientific Reports
- The NorthStar Ambulatory Assessment in Duchenne muscular dystrophy: considerations for the design of clinical trials
- (2015) Valeria Ricotti et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Duchenne muscular dystrophy
- (2015) Eppie M Yiu et al. JOURNAL OF PAEDIATRICS AND CHILD HEALTH
- Developmental myosins: expression patterns and functional significance
- (2015) Stefano Schiaffino et al. Skeletal Muscle
- Duchenne and Becker Muscular Dystrophies
- (2014) Kevin M. Flanigan NEUROLOGIC CLINICS
- Eteplirsen for the treatment of Duchenne muscular dystrophy
- (2013) Jerry R. Mendell et al. ANNALS OF NEUROLOGY
- Dystrophin complex functions as a scaffold for signalling proteins
- (2013) Bruno Constantin BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- Low dystrophin levels increase survival and improve muscle pathology and function in dystrophin/utrophin double-knockout mice
- (2013) Maaike van Putten et al. FASEB JOURNAL
- Phase 2a Study of Ataluren-Mediated Dystrophin Production in Patients with Nonsense Mutation Duchenne Muscular Dystrophy
- (2013) Richard S. Finkel et al. PLoS One
- Biochemical Characterization of Patients With In-Frame or Out-of-FrameDMDDeletions Pertinent to Exon 44 or 45 Skipping
- (2013) Karen Anthony et al. JAMA Neurology
- Evidence-based path to newborn screening for duchenne muscular dystrophy
- (2012) Jerry R. Mendell et al. ANNALS OF NEUROLOGY
- The Effects of Low Levels of Dystrophin on Mouse Muscle Function and Pathology
- (2012) Maaike van Putten et al. PLoS One
- Dystrophin quantification and clinical correlations in Becker muscular dystrophy: implications for clinical trials
- (2011) K. Anthony et al. BRAIN
- The Dystrophin-Glycoprotein Complex in the Prevention of Muscle Damage
- (2011) Jessica D. Gumerson et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study
- (2011) Sebahattin Cirak et al. LANCET
- Restoration of the Dystrophin-associated Glycoprotein Complex After Exon Skipping Therapy in Duchenne Muscular Dystrophy
- (2011) Sebahattin Cirak et al. MOLECULAR THERAPY
- Physiological Characterization of Muscle Strength With Variable Levels of Dystrophin Restoration in mdx Mice Following Local Antisense Therapy
- (2010) Paul S Sharp et al. MOLECULAR THERAPY
- Chronic Systemic Therapy With Low-dose Morpholino Oligomers Ameliorates the Pathology and Normalizes Locomotor Behavior in mdx Mice
- (2010) Alberto Malerba et al. MOLECULAR THERAPY
- Theoretic applicability of antisense-mediated exon skipping for Duchenne muscular dystrophy mutations
- (2009) Annemieke Aartsma-Rus et al. HUMAN MUTATION
- Preservation of Muscle Force in Mdx3cv Mice Correlates with Low-Level Expression of a Near Full-Length Dystrophin Protein
- (2008) Dejia Li et al. AMERICAN JOURNAL OF PATHOLOGY
- Direct observation of failing fibers in muscles of dystrophic mice provides mechanistic insight into muscular dystrophy
- (2008) Dennis R. Claflin et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started